Search

Your search keyword '"Dermatitis Herpetiformis chemically induced"' showing total 28 results
Start Over Descriptor "Dermatitis Herpetiformis chemically induced"
28 results on '"Dermatitis Herpetiformis chemically induced"'

3. Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma.

Author

Mochel MC, Ming ME, Imadojemu S, Gangadhar TC, Schuchter LM, Elenitsas R, Payne AS, and Chu EY

Subjects
Adult, Autoimmune Diseases chemically induced, Autoimmune Diseases pathology, Dermatitis Herpetiformis pathology, Drug Eruptions etiology, Female, Humans, Ipilimumab, Male, Melanoma drug therapy, Melanoma secondary, Middle Aged, Pemphigoid, Bullous pathology, Skin Neoplasms drug therapy, Skin Neoplasms secondary, Antibodies, Monoclonal adverse effects, Antibodies, Monoclonal, Humanized adverse effects, Antineoplastic Agents adverse effects, Dermatitis Herpetiformis chemically induced, Drug Eruptions pathology, Pemphigoid, Bullous chemically induced
Abstract

Therapeutic immune checkpoint blockade for metastatic melanoma has been associated with vitiligo, pruritus and morbilliform eruptions. Reports of other autoimmune skin disease in this setting are rare. We sought to expand the spectrum of cutaneous immune-mediated effects related to immune checkpoint inhibitor therapy. In this report, we describe two unusual cutaneous reactions related to checkpoint inhibitor therapy, namely bullous pemphigoid (BP) and dermatitis herpetiformis. The development of BP and dermatitis herpetiformis in the context of checkpoint inhibitor therapy is consistent with previous investigations supporting the importance of effector and regulatory T cells in the pathogenesis of these diseases., (© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)

Published
2016
Full Text
View/download PDF

6. Impetigo herpetiformis occurring during N-butyl-scopolammonium bromide therapy in pregnancy: case report.

Author

Guerriero C, Lanza Silveri S, Sisto T, Rosati D, De Simone C, Fossati B, Pomini F, Rotoli M, Amerio P, and Capizzi R

Subjects
Adult, Dermatitis Herpetiformis pathology, Female, Humans, Impetigo pathology, Male, Pregnancy, Butylscopolammonium Bromide adverse effects, Dermatitis Herpetiformis chemically induced, Dermatitis Herpetiformis complications, Impetigo chemically induced, Impetigo complications
Abstract

Impetigo herpetiformis (IH) is a rare dermatosis arising during the third trimester of pregnancy which is generally considered as a form of pustular psoriasis of unknown aetiology. Clinically it is characterized by erythematous plaques surrounded by sterile pustules associated with fever, diarrhea, sweating and increasing risk of stillbirth for placental insufficiency. We describe a case of developed erythematous plaques surrounded by pustules localised initially to the trunk of a 35-year-old woman at the 34th week of gestation after 5 days of treatment with N-Butyl-Scopolammonium, and which later involved the upper and lower limbs. Skin histology confirmed the diagnosis of generalised pregnancy pustular psoriasis (impetigo herpetiformis). IH is reported to be associated with hypocalcemia, hypoparathyroidism, use of oral contraceptives and bacterial infections. This is the first report suggesting the potential role of drugs other than oral contraceptives in the pathogenetic mechanism of this disease. In this case an adverse cutaneous reaction to BB could be the cause of the development of Koebner isomorphism.

Published
2008

11. Leuprolide acetate-induced dermatitis herpetiformis.

Author

Grimwood RE and Guevara A

Subjects
Aged, Antineoplastic Agents, Hormonal administration & dosage, Humans, Leuprolide administration & dosage, Male, Prostatic Neoplasms drug therapy, Antineoplastic Agents, Hormonal adverse effects, Dermatitis Herpetiformis chemically induced, Leuprolide adverse effects
Abstract

Dermatitis herpetiformis (DH) is a chronic, pruritic, papulovesicular dermatosis on extensor surfaces that is characterized by a neutrophilic infiltrate and granular immunoglobulin A deposition at the dermal papillae. Although the presence of immunoglobulin A in the skin and the severity of DH are known to be associated with gluten intake, few drugs have been implicated in the induction of DH. We report a case of DH triggered by intramuscular injections of leuprolide acetate, a gonadotropin-releasing hormone analog, in a patient with a history of prostate cancer.

Published
2005

12. Multiple IgA autoantibodies associated with mefenamic acid.

Author

Gerbig AW, Paredes B, and Hunziker T

Subjects
Female, Humans, Middle Aged, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Autoantibodies metabolism, Dermatitis Herpetiformis chemically induced, Dermatitis Herpetiformis immunology, Immunoglobulin A immunology, Mefenamic Acid adverse effects
Published
1998
Full Text
View/download PDF

13. Quinolone allergy?

Author

Landor M, Lashinsky A, and Waxman J

Subjects
Biopsy, Ciprofloxacin adverse effects, Dermatitis Herpetiformis chemically induced, Dermatitis Herpetiformis diagnosis, Diagnosis, Differential, Drug Eruptions classification, Drug Eruptions diagnosis, Erythema Multiforme diagnosis, Humans, Male, Middle Aged, Pemphigoid, Bullous chemically induced, Pemphigoid, Bullous diagnosis, Pemphigoid, Bullous pathology, Skin pathology, Drug Hypersensitivity etiology, Quinolones adverse effects
Published
1996
Full Text
View/download PDF

16. [Pemphigus herpetiformis following D-penicillamine in a patient with HLA B8].

Author

Weltfriend S, Ingber A, David M, and Sandbank M

Subjects
Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid immunology, Dermatitis Herpetiformis pathology, HLA-B Antigens analysis, HLA-B8 Antigen, Humans, Male, Middle Aged, Pemphigus pathology, Penicillamine therapeutic use, Skin pathology, Dermatitis Herpetiformis chemically induced, Drug Eruptions etiology, Pemphigus chemically induced, Penicillamine adverse effects
Abstract

A 57-year-old patient with rheumatoid arthritis, who was being treated with D-penicillamine, developed a bullous eruption 2 months after the onset of treatment. On the basis of the clinical, histological and immunofluorescent findings, the diagnosis of herpetiform pemphigus was made. The eruptions disappeared within 2 weeks after the discontinuation of D-penicillamine treatment. During the 16-month follow-up period there was no recurrence. It is noteworthy that a patch test with potassium iodide was positive and that testing for HLA antigens revealed HLA B8, A1, A2, and BW39.

Published
1988

17. Dermatitis herpetiformis. A case provoked by iodine.

Author

From E and Thomsen K

Subjects
Aged, Dermatitis Herpetiformis immunology, Dermatitis Herpetiformis pathology, Dermatitis Herpetiformis therapy, Diet Therapy, Fluorescent Antibody Technique, Humans, Immunoglobulin A analysis, Male, Nonprescription Drugs, Dermatitis Herpetiformis chemically induced, Iodine adverse effects
Published
1974
Full Text
View/download PDF

18. The neurotoxicity of dapsone.

Author

Daneshmend TK

Subjects
Adolescent, Adult, Animals, Child, Dapsone therapeutic use, Dermatitis Herpetiformis chemically induced, Electrophysiology drug effects, Female, Guinea Pigs, Humans, Leprosy drug therapy, Male, Middle Aged, Movement Disorders chemically induced, Muscles drug effects, Neurons, Afferent drug effects, Peripheral Nerves drug effects, Psychomotor Disorders chemically induced, Psychoses, Substance-Induced etiology, Rats, Reflex drug effects, Vision Disorders chemically induced, Dapsone adverse effects, Peripheral Nervous System Diseases chemically induced
Published
1984

19. Dermatitis herpetiformis exacerbated by indomethacin.

Author

Griffiths CE, Leonard JN, and Fry L

Subjects
Adult, Aged, Dapsone therapeutic use, Dermatitis Herpetiformis drug therapy, Female, Humans, Male, Middle Aged, Sulfamethoxypyridazine therapeutic use, Dermatitis Herpetiformis chemically induced, Indomethacin adverse effects
Abstract

Thirteen adults with dermatitis herpetiformis (DH) controlled by dapsone or sulphamethoxypyridazine were given indomethacin or placebo in a double-blind cross-over study. In nine of the thirteen patients the rash and pruritus of DH were exacerbated more by indomethacin than by placebo. Dapsone and sulphamethoxypyridazine requirements were increased during the indomethacin period. The involvement of lipoxygenase products in the pathogenesis of the DH skin lesions is postulated.

Published
1985
Full Text
View/download PDF

21. Letter: Dermatitis herpetiformis, iodine compounds and thyrotoxicosis.

Author

Douglas WS and Alexander JO

Subjects
Adult, Aged, Carbimazole administration & dosage, Carbimazole therapeutic use, Dapsone therapeutic use, Dermatitis Herpetiformis diet therapy, Dermatitis Herpetiformis drug therapy, Female, Glutens adverse effects, Humans, Hyperthyroidism drug therapy, Male, Middle Aged, Sulfapyridine therapeutic use, Thyroxine therapeutic use, Dermatitis Herpetiformis chemically induced, Iodine adverse effects
Published
1975
Full Text
View/download PDF

23. [Hailey-Hailey disease with dissemination and eczema herpeticatum in therapy with etretinate].

Author

Stallmann D and Schmoeckel C

Subjects
Adult, Dermatitis Herpetiformis pathology, Drug Therapy, Combination, Etretinate therapeutic use, Humans, Male, Pemphigus chemically induced, Pemphigus pathology, Scrotum pathology, Skin pathology, Candidiasis, Cutaneous pathology, Dermatitis Herpetiformis chemically induced, Drug Eruptions pathology, Etretinate adverse effects, Pemphigus drug therapy
Abstract

We report a 39-year-old patient with Hailey-Hailey disease localized mainly in the genito-femoral and scrotal areas. During hospital treatment the condition worsened due to superinfection with Candida albicans and gram-negative bacteria. Treatment with systemic steroids followed by aromatic retinoids was tried: eczema herpeticum developed in the affected areas, and dissemination of Hailey-Hailey disease ultimately occurred with papulo-vesicular and histologically characteristic lesions.

Published
1988

27. Hormonal factors in dermatitis herpetiformis. Report of two cases.

Author

Haim S and Friedman-Birnbaum R

Subjects
Adolescent, Adult, Dapsone therapeutic use, Female, Humans, Male, Menstruation, Recurrence, Remission, Spontaneous, Contraceptives, Oral adverse effects, Dermatitis Herpetiformis chemically induced, Estrogens adverse effects, Progesterone adverse effects
Published
1972
Full Text
View/download PDF

28. [Gangrenous herpes zoster imitating penicilline lesions].

Author

Angyal J and Mesko E

Subjects
Aged, Dermatitis Herpetiformis diagnosis, Diagnosis, Differential, Female, Herpes Simplex, Herpes Zoster diagnosis, Humans, Penicillins therapeutic use, Dermatitis Herpetiformis chemically induced, Drug Eruptions etiology, Penicillins adverse effects
Published
1972

Catalog

Books, media, physical & digital resources
See catalog results